|
| 37079810 | Relationships between hourly cognitive variability and risk of Alzheimer's disease revealed with mixed-effects location scale models. | Neuropsychology | 2024 |
| 37698424 | The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. | Alzheimers Dement | 2024 |
| 37740921 | Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network. | Alzheimers Dement | 2024 |
| 37782554 | Improving Early Recognition of Treatment-Responsive Causes of Rapidly Progressive Dementia: The STAM<sub>3</sub> P Score. | Ann Neurol | 2024 |
| 37610059 | Mapping sleep's oscillatory events as a biomarker of Alzheimer's disease. | Alzheimers Dement | 2024 |
| 35953305 | Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease. | J Nucl Med | 2023 |
| 37867465 | T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease. | Hum Brain Mapp | 2023 |
| 37707812 | Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening. | JAMA Netw Open | 2023 |
| 37483329 | Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease. | J Alzheimers Dis Rep | 2023 |
| 37548931 | Alzheimer Disease Pathology and Neurodegeneration in Midlife Obesity: A Pilot Study. | Aging Dis | 2023 |
| 37843849 | Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. | JAMA Neurol | 2023 |
| 37544835 | Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment. | Am J Geriatr Psychiatry | 2023 |
| 37732218 | Chronotype is Associated with Sleep Quality in Older Adults. | medRxiv | 2023 |
| 37773496 | Medication and Road Test Performance Among Cognitively Healthy Older Adults. | JAMA Netw Open | 2023 |
| 37534906 | Effect of exercise engagement and cardiovascular risk on neuronal injury. | Alzheimers Dement | 2023 |
| 37563879 | White matter hyperintensity longitudinal morphometric analysis in association with Alzheimer disease. | Alzheimers Dement | 2023 |
| 37532510 | Association Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic. | Neurology | 2023 |
| 35609137 | Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease. | Alzheimers Dement | 2023 |
| 35362200 | Biomarker clustering in autosomal dominant Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37291760 | Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. | Aging Cell | 2023 |
| 37087693 | Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study. | Alzheimers Dement | 2023 |
| 37085492 | Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. | Nat Commun | 2023 |
| 36989588 | Cortical atrophy and leukoaraiosis, imaging markers of cerebrovascular small vessel disease, are associated with driving behavior changes among cognitively normal older adults. | J Neurol Sci | 2023 |
| 37117788 | CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. | Nat Aging | 2023 |
| 37016671 | Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease. | medRxiv | 2023 |
| 37315112 | Gut microbiome composition may be an indicator of preclinical Alzheimer's disease. | Sci Transl Med | 2023 |
| 37145978 | Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities. | Alzheimer Dis Assoc Disord | 2023 |
| 36978190 | Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. | Alzheimers Res Ther | 2023 |
| 37443334 | CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. | Nat Med | 2023 |
| 37076305 | Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals. | Neurology | 2023 |
| 37406134 | Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease. | Sci Transl Med | 2023 |
| 37202169 | Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span. | Neurology | 2023 |
| 37365110 | Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression. | Am J Geriatr Psychiatry | 2023 |
| 37067479 | Increased cognitive effort costs in healthy aging and preclinical Alzheimer's disease. | Psychol Aging | 2023 |
| 37429916 | Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). | Nat Neurosci | 2023 |
| 37092225 | Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment. | J Alzheimers Dis | 2023 |
| 36993867 | Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration. | Nat Aging | 2023 |
| 37461624 | Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies <i>LRRC4C, LHX5-AS1</i> and nominates ancestry-specific loci <i>PTPRK</i> , <i>GRB14</i> , and <i>KIAA0825</i> as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. | medRxiv | 2023 |
| 36625756 | Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease. | Brain | 2023 |
| 36522155 | First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study. | J Neurol Neurosurg Psychiatry | 2023 |
| 36749854 | Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus. | Alzheimers Dement | 2023 |
| 36748000 | Gene-SGAN: a method for discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clustering. | ArXiv | 2023 |
| 36745794 | Brain aerobic glycolysis and resilience in Alzheimer disease. | Proc Natl Acad Sci U S A | 2023 |
| 36542469 | Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression. | Brain | 2023 |
| 36874595 | Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. | Alzheimers Dement (Amst) | 2023 |
| 36610788 | Plasma Aβ42/Aβ40 Ratios in Older People With Human Immunodeficiency Virus. | Clin Infect Dis | 2023 |
| 36843330 | Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease. | Ann Neurol | 2023 |
| 36576155 | Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. | Alzheimers Dement | 2023 |
| 36935765 | A practitioner's guide to geospatial analysis in a neuroimaging context. | Alzheimers Dement (Amst) | 2023 |
| 36641615 | Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease. | J Prev Alzheimers Dis | 2023 |